article thumbnail

Fractional flow reserve and instantaneous wave-free ratio in coronary artery bypass grafting: a meta-analysis and practice review

Frontiers in Cardiovascular Medicine

Both indexes have been extensively validated in clinical trials in guiding revascularisation in patients with stable ischaemic heart disease undergoing percutaneous coronary intervention (PCI) with improved clinical outcomes. However, the role of these tools in coronary artery bypass grafting (CABG) is less clear.

article thumbnail

Retrosternal hematoma causing torsade de pointes after coronary artery bypass graft surgery; a case report

Frontiers in Cardiovascular Medicine

Myocardial infarction is among the top causes of mortality worldwide. Infarct-related torsade de pointes (TdP) is an uncommon complication. In the context of myocardial infarction, coronary artery bypass graft (CABG) surgery is the prevalent therapeutic modality associated with several early and late complications.

article thumbnail

Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting in Patients With Left Main Disease With or Without Diabetes: Findings From a Pooled Analysis of 4 Randomized Clinical Trials

Circulation

BACKGROUND:Diabetes may be associated with differential outcomes in patients undergoing left main coronary revascularization with percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG). 1.52]) or without (155/1634 [9.7%] versus 142/1655 [8.9%]; hazard ratio, 1.08 [95% CI, 0.86–1.36;PintHR=0.87)

article thumbnail

Postdischarge major bleeding, myocardial infarction, and mortality risk after coronary artery bypass grafting

Heart BMJ

Objective To investigate the incidence and mortality risk associated with postdischarge major bleeding after coronary artery bypass grafting (CABG), and relate this to the incidence of, and mortality risk from, postdischarge myocardial infarction. Median follow-up was 6.0 range 0–11) years. 95% CI 3.4

article thumbnail

The association of perioperative serum uric acid variation with in-hospital adverse outcomes in coronary artery bypass grafting patients

Frontiers in Cardiovascular Medicine

BackgroundPrevious studies proposed the predictive value of baseline serum uric acid (SUA) in the prognosis of coronary artery bypass grafting (CABG) patients. The cutoff values of SUA increases in the overall population were 54.5 µmol/L µmol/L for in-hospital all-cause death and 42.6 µmol/L

article thumbnail

Propensity score-based comparison of high-risk coronary artery bypass grafting vs. left ventricular assist device implantation in patients with coronary artery disease and advanced heart failure

Frontiers in Cardiovascular Medicine

In this setting, implantation of a durable left ventricular assist device (LVAD) might be an alternative.MethodsWe retrospectively compared the outcomes of adult patients with CAD and a left ventricular ejection fraction (LVEF) ≤ 25% who underwent coronary artery bypass grafting (CABG) vs. LVAD implantation.

article thumbnail

Early and late outcomes after minimally invasive direct coronary artery bypass vs. full sternotomy off-pump coronary artery bypass grafting

Frontiers in Cardiovascular Medicine

IPTW-adjusted Kaplan–Meier estimates by study group were calculated for all-cause mortality, stroke, the risk of repeat revascularization and myocardial infarction up to a maximum follow-up of 10 years. Results MIDCAB patients had less rethoracotomies ( n  = 13/3.6% vs. n  = 30/8.0%, p  = 0.012), fewer transfusions (0.93 units ± 1.83